Dr. Benjamin Lowry, M.D.
What this data tells you about Dr. Lowry
Dr. Benjamin Lowry is an anesthesiology in Temple, TX, with 17 years in practice. Based on federal Medicare data, Dr. Lowry performed 1,070 Medicare services across 628 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lowry received a total of $46,747 from 19 pharmaceutical and/or device companies across 730 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lowry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) | 425 | $0 | $5 |
| Office visit, established patient (30-39 min) | 288 | $70 | $316 |
| Drug screening test | 79 | $59 | $350 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 59 | $192 | $497 |
| Testing for presence of drug, read by direct observation | 29 | $12 | $50 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 22 | $242 | $617 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 20 | $70 | $226 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 16 | $80 | $455 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 16 | $45 | $288 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 15 | $56 | $387 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 15 | $51 | $453 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $91 | $416 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $66 | $213 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 13 | $145 | $1,000 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 13 | $153 | $391 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 11 | $338 | $1,097 |
| Ultrasonic guidance for needle placement | 11 | $44 | $133 |
| New patient office visit (45-59 min) | 11 | $79 | $408 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (53%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for anesthesiology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lowry is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), and high industry engagement (consulting-driven, top 1%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lowry experienced with dexamethasone injection (steroid)?
Does Dr. Lowry receive payments from pharmaceutical companies?
How do Dr. Lowry's costs compare to other anesthesiologys in Temple?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology